Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > JPK boosts its position in Molecular Analytics with complete takeover of nAmbition subsidiary

Abstract:
JPK Instruments AG, one of the leading developers of measuring and analytical instruments in the nanotechnology field, has increased its share in JPK subsidiary nAmbition GmbH in Dresden to 100 percent. Thus the Berlin-based company was able to extend its product portfolio and significantly boost its Molecular Analytics division.

JPK boosts its position in Molecular Analytics with complete takeover of nAmbition subsidiary

Berlin, Germany | Posted on January 8th, 2008

Founded in 2004, nAmbition develops, products and markets analytical instruments based on nanotechnological methods. The company is thus positioned in the rapidly growing market for instruments and techniques used in nanobiotechnology and molecular biology. For example, ForceRobot®, a product developed by the Dresden-based company and launched in 2007, is the first product of its kind that enables automated measurements on individual molecules, thus producing a protein fingerprint. Among other applications, this feature can be used to identify where active ingredients in drugs bind to the target molecule, as well as the strength of the resultant binding. For the first time it is now possible to gain targeted insights into the complex interactions of individual bio-molecules with active ingredients, thus opening up new paths in the field of pharmaceutical research. In addition to ForceRobot®, which has already generated initial sales, further high-margin projects are also in development.

"The complete takeover of nAmbition now provides us with an opportunity to exploit major synergy potential. We will integrate nAmbition into our overall marketing and sales structure and further boost its sales and earnings contributions," comments Frank Pelzer, CEO of JPK Instruments AG, with regard to the acquisition of shares from investment company Dresden Fonds GmbH, which has actively accompanied the development of nAmbition as a financing partner since 2005.

The development expertise and products of nAmbition ideally complement JPK's portfolio and will significantly strengthen its Molecular Analytics division. Besides growth in sales and long-term improvement of earnings, the Berlin-based company also expects the acquisition to be helpful in winning new customer groups.

Following the complete takeover, JPK Group has two subsidiaries now: nAmbition GmbH and light power instruments GmbH. Not only do both companies possess a high degree of technological expertise, but both subsidiaries as well as the parent company own numerous patents which represent considerable barriers to competitors entering the market. "We are pleased with our complete integration into the JPK family," comments Dr. Jens Struckmeier, Technical Managing Director of nAmbition GmbH. "It will facilitate our cooperation and provide both sides with greater opportunities for exchanging their respective expertise and exploiting existing structures and synergy potential. With JPK Instruments AG, we will also have a parent company on our side which has yielded positive results since 2004. This underlines JPK's extraordinary position as a German company in the growing nanotechnology field."

####

About JPK Instruments AG
JPK Instruments AG is a leading manufacturer of nano-analytic instruments – particularly atomic force microscope (AFM) systems – for research in life sciences and soft matter. One of Germany’s most innovative nanotechnology companies, JPK was among the first to recognize the revolutionary opportunities this new field would open up for biomedical and pharmaceutical research. From the beginning, JPK has tailored its instrument platforms to meet the challenges in these areas.

JPK has developed powerful state-of-the-art solutions for high-resolution imaging, force measurement, nanomanipulation and nanolithography for life science applications. At the center of JPK’s current portfolio are the BioAFM NanoWizard®, the CellHesion® module (for studying cell adhesion and cell mechanics phenomena), and the TAO module (for use in optical spectroscopy). The secret of JPK’s success lies in its high level of application expertise and its close interaction with leading scientists and research centers in nanotechnology.

Founded in 1999, the company is headquartered in Berlin and maintains a global network of distributors and support centers. In 2004 it launched nAmbition GmbH, a Dresden subsidiary specializing in the development of nano-instruments for application in molecular medicine and pharmaceutical research. In August 2006, this was followed by the 100% acquisition of lpi light power instruments, which is focussing on the development of optical nano-instrumentation for life science applications in research and industry.

For more information, please click here

Contacts:
Dr. Gabriela Bagordo

+49 (30) 5331-12541
Fax: +49 (30) 5331-22555
Communication Manager

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nano Ruffles in Brain Matter: Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function October 31st, 2014

Gold nanoparticle chains confine light to the nanoscale October 31st, 2014

'Nanomotor lithography' answers call for affordable, simpler device manufacturing October 31st, 2014

Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014

Announcements

Nano Ruffles in Brain Matter: Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function October 31st, 2014

Gold nanoparticle chains confine light to the nanoscale October 31st, 2014

'Nanomotor lithography' answers call for affordable, simpler device manufacturing October 31st, 2014

Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014

Tools

Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014

A new cheap and efficient method to improve SERS, an ultra-sensitive chemical detection technique October 28th, 2014

New Compact SIMS at 61st AVS | Visit us on Booth 311 October 28th, 2014

New nanodevice to improve cancer treatment monitoring October 27th, 2014

Acquisitions/Mergers/Splits

PEN Inc. Chairman, Scott Rickert, Will Webcast a Live Company Update September 25, 1 PM EDT September 17th, 2014

State University of New York Trustees Unanimously Approve SUNY Polytechnic Institute (SUNY Poly) as New Name for Merged SUNY CNSE / SUNYIT September 9th, 2014

PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014

Applied Nanotech Holdings, Inc. and NanoHoldings Inc. Complete Combination to Create PEN Inc.: New Company to Focus on Commercialization of Advanced Nanotechnology-Enabled Products; Scott Rickert Is Chairman and CEO September 2nd, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE